Cancer patients don't trust docs: survey

Share this article:
A survey of patients at Harvard's Dana-Farber Cancer Institute found that 11% said ads for cancer-related drugs had made them less confident in their providers' judgment.

Of the 348 respondents to the survey, in the Journal of Clinical Oncology, 86% were aware of DTC advertising, particularly TV spots (77%), with little variation across clinical or sociodemographic factors except that patients were more likely to be aware of products specific to their cancer types. Of those aware of ads, 17.3% said they'd talked to their healthcare provider about an advertised medication. Patient perceptions of DTC ads were favorable, particularly among non-college graduates.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Pharmaceutical

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.